135 related articles for article (PubMed ID: 35142098)
1. Wilms tumour treatment in Sudan: A 10-year single-centre experience.
Abdalla M; Hameed S
Cancer Rep (Hoboken); 2022 Nov; 5(11):e1604. PubMed ID: 35142098
[TBL] [Abstract][Full Text] [Related]
2. Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 study.
Daw NC; Chi YY; Kim Y; Mullen EA; Kalapurakal JA; Tian J; Khanna G; Geller JI; Perlman EJ; Ehrlich PF; Warwick AB; Grundy PE; Fernandez CV; Dome JS;
Eur J Cancer; 2019 Sep; 118():58-66. PubMed ID: 31325873
[TBL] [Abstract][Full Text] [Related]
3. Wilms tumour in Sudan.
Abuidris DO; Elimam ME; Nugud FM; Elgaili EM; Ahmed ME; Arora RS
Pediatr Blood Cancer; 2008 Jun; 50(6):1135-7. PubMed ID: 18384057
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and Clinical Outcomes of Children With Wilms' Tumour: A 15-year Experience in a Single Centre in Nigeria.
Nasir AA; Abdur-Raheem NT; Abdur-Rahman LO; Ibiyeye TT; Sayomi TO; Adedoyin OT; Adeniran JO
J Pediatr Surg; 2024 May; 59(5):1009-1014. PubMed ID: 38184433
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Wilms' tumour. Current recommendations.
Mehta MP; Bastin KT; Wiersma SR
Drugs; 1991 Nov; 42(5):766-80. PubMed ID: 1723373
[TBL] [Abstract][Full Text] [Related]
6. Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.
Fernandez CV; Mullen EA; Chi YY; Ehrlich PF; Perlman EJ; Kalapurakal JA; Khanna G; Paulino AC; Hamilton TE; Gow KW; Tochner Z; Hoffer FA; Withycombe JS; Shamberger RC; Kim Y; Geller JI; Anderson JR; Grundy PE; Dome JS
J Clin Oncol; 2018 Jan; 36(3):254-261. PubMed ID: 29211618
[TBL] [Abstract][Full Text] [Related]
7. A 5-year multidisciplinary care outcomes in children with wilms' tumour managed at a tertiary centre: A retrospective observational study.
Alakaloko FM; Akinsete AM; Seyi-Olajide JO; Joseph AO; Elebute OO; Ladipo-Ajayi OA; Odubanjo MO; Olowoyeye OA; Ademuyiwa AO; Temiye EO; Akinsulie AA; Bode CO
Afr J Paediatr Surg; 2022; 19(2):83-88. PubMed ID: 35017377
[TBL] [Abstract][Full Text] [Related]
8. MANAGEMENT AND OUTCOME OF PATIENTS WITH WILMS' TUMOUR (NEPHROBLASTOMA) AT THE MOI TEACHING AND REFERRAL HOSPITAL, ELDORET, KENYA.
Tenge CN; Were PA; Aluoch LH; Wekesa JW; Patel K; Kuremu RT
East Afr Med J; 2012 Apr; 89(4):121-7. PubMed ID: 26856036
[TBL] [Abstract][Full Text] [Related]
9. Optimal neoadjuvant chemotherapy duration in Wilms tumour with intravascular thrombus: A literature review and evidence from SIOP WT 2001 trial.
Morris L; Squire R; Sznajder B; van Tinteren H; Godzinski J; Powis M
Pediatr Blood Cancer; 2019 Nov; 66(11):e27930. PubMed ID: 31339231
[TBL] [Abstract][Full Text] [Related]
10. [Wilms' tumour: A review of 15 years recent experience].
Illade L; Hernandez-Marques C; Cormenzana M; Lassaletta Á; Andión Catalán M; Ruano D; Fioravantti V; Madero López L
An Pediatr (Engl Ed); 2018 Mar; 88(3):140-149. PubMed ID: 28479004
[TBL] [Abstract][Full Text] [Related]
11. [Bilateral Wilms' tumour. Results of treatment in 29 children].
Sawicz-Birkowska K; Apoznanski W; Dembowska-Bagińska B; Balcerska A; Szymik-Kantorowicz S; Perek D; Wachowiak J; Wysocki M; Klepacka T; Zaleska-Dorobisz U
Med Wieku Rozwoj; 2003; 7(3):369-80. PubMed ID: 14963344
[TBL] [Abstract][Full Text] [Related]
12. Wilms tumour experience in a South African centre.
Davidson A; Hartley P; Desai F; Daubenton J; Rode H; Millar A
Pediatr Blood Cancer; 2006 Apr; 46(4):465-71. PubMed ID: 16342063
[TBL] [Abstract][Full Text] [Related]
13. Wilms' tumour: a 30 year experience at Wellington Hospital.
Delahunt B; Nacey JN; Lewis ME; Pringle KC; Russell GL
N Z Med J; 1990 Jun; 103(891):267-9. PubMed ID: 2162507
[TBL] [Abstract][Full Text] [Related]
14. Challenges and outcome of Wilms' tumour management in a resource-constrained setting.
Wilde JC; Lameris W; van Hasselt EH; Molyneux EM; Heij HA; Borgstein EG
Afr J Paediatr Surg; 2010; 7(3):159-62. PubMed ID: 20859020
[TBL] [Abstract][Full Text] [Related]
15. Treatment of children with favorable histology Wilms tumor with extrapulmonary metastases: A report from the COG studies AREN0533 and AREN03B2 and NWTSG study NWTS-5.
Benedetti DJ; Varela CR; Renfro LA; Tornwall B; Dix DB; Ehrlich PF; Glick RD; Kalapurakal J; Perlman E; Gratias E; Seibel NL; Geller JI; Khanna G; Malogolowkin M; Grundy P; Fernandez CV; Dome JS; Mullen EA
Cancer; 2024 Mar; 130(6):947-961. PubMed ID: 37933882
[TBL] [Abstract][Full Text] [Related]
16. Adult Wilms tumour.
Zdrojowy R; Sawicz-Birkowska K; Apoznański W; Patkowski D; Szydełko T; Pietras W; Dembowski J
Int Urol Nephrol; 2011 Sep; 43(3):691-6. PubMed ID: 21110097
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report.
Dix DB; Fernandez CV; Chi YY; Mullen EA; Geller JI; Gratias EJ; Khanna G; Kalapurakal JA; Perlman EJ; Seibel NL; Ehrlich PF; Malogolowkin M; Anderson J; Gastier-Foster J; Shamberger RC; Kim Y; Grundy PE; Dome JS;
J Clin Oncol; 2019 Oct; 37(30):2769-2777. PubMed ID: 31449468
[TBL] [Abstract][Full Text] [Related]
18. Wilms' tumour. Optimal treatment strategies.
Suryanarayan K; Marina N
Drugs; 1998 Oct; 56(4):598-605. PubMed ID: 9806106
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of children with favorable histology wilms tumor and peritoneal implants treated in National Wilms Tumor Studies-4 and -5.
Kalapurakal JA; Green DM; Haase G; Anderson JR; Dome JS; Grundy PE
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):554-8. PubMed ID: 20457352
[TBL] [Abstract][Full Text] [Related]
20. [Wilms' tumour of unfavorable histology--results of treatment with the SIOP 93-01 protocol at the Gdańsk centre. Preliminary report].
Stefanowicz J; Sierota D; Balcerska A; Stoba C
Med Wieku Rozwoj; 2004; 8(2 Pt 1):197-200. PubMed ID: 15738594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
